Ken Griffin Third Harmonic Bio, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$5.97 - $11.47 $2.17 Million - $4.16 Million	363,028 New	363,028 $3.98 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $4.49 $42,359 - $48,150	10,724 New	10,724 $44,000
Q3 2022 Nov 14, 2022	BUY	N/A	57,687 New	57,687 $1.1 Million

Others Institutions Holding THRD

# of Institutions

68

Shares Held

35.8M

Call Options Held

0

Put Options Held

0

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$130 Million
12.88% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$69.1 Million
1.23% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$52.2 Million
1.23% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$38 Million
0.86% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$35.4 Million
0.65% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $482M

More about THRD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.